Shane Hegarty

Shane Hegarty

Shane Hegarty

Chief Scientific Officer & Co-Founder

Biography

Dr Shane Hegarty graduated as the top ranked student of Neuroscience BSc with a 1st Class Hons from UCC in 2010, having been awarded the distinction of ‘College Scholar’ in 2007, 2008, 2009 and 2010, and the ‘Certificate of Excellence’ in 2010 for academic excellence.

In 2010, he was awarded the prestigious ‘IRCSET EMBARK Postgraduate Scholarship’ by Irish Research Council (IRC) to carry out his proposed PhD project in Dept. Anatomy & Neuroscience, UCC, under the supervision of Professor Aideen Sullivan & Dr Gerard O’Keeffe. He was awarded the highly competitive ‘Government of Ireland Post-Doctoral Fellowship’ by the IRC in 2014, and the ‘NUI Post-Doctoral Fellowship in the Sciences by the National University of Ireland in 2015, to facilitate his Post-Doctoral research in the Dept. of Anatomy and Neuroscience, UCC, which built on his PhD work.

As a researcher, he has been awarded places on international training courses, travel bursaries and ‘best presentation’ at a number of conferences. He has published 28 peer-reviewed journal articles (19 first author; 4 senior authors) to date, which have generated >1000 citations and an ‘h-index’ of 15. In 2015 he was awarded IRC ‘New Foundation Award’ to launch the ongoing ‘BRAINTALK’ outreach project. He was awarded the prestigious ‘Charlemont Grant’ in 2016 from Royal Irish Academy to extend his research in Prof. Danny Huylebroeck’s laboratory in Erasmus MC, Netherlands and KU Leuven, Belgium. In August 2016, he was appointed as a full-time Lecturer in the Dept. of Anatomy & Neuroscience, UCC. In September 2016

Shane was awarded the prestigious Neuroscience Ireland Early Career Investigator Award’ which recognises ‘outstanding Neuroscience research’. In August 2017, Dr Hegarty began his employment as a Research Fellow in the laboratory of Professor Zhigang He, in the Dept. of Neurology, Boston Children’s Hospital and Harvard. In Sept. 2018, he became an Adjunct Professor at Wentworth Institute of Technology. In January 2020, as a principal investigator he was granted a ‘William Randolph Hearst Fund Award’ for 2020 by the William Randolph Hearst Foundation in recognition of, and to progress, his research work in HMS/BCH. In Jan. 2021

Shane joined Harvard i-Labs and President’s Innovation Challenge to spin out these recent discoveries. In April 2021, Dr Hegarty became Chief Scientific Officer and Co-Founder of AXONIS Therapeutics, to pursue his lifelong mission of developing new therapies for neurological disorders.

back to top

Call For Abstracts


    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.